Oxidative stress markers in intestinal mucosa of Tunisian inflammatory bowel disease patients

Saudi Journal of Gastroenterology

Volumn 19, Issue 3, 2013, Pages 131-135

  Bouzid, Dorra ^a   Gargouri, Bochra ^b   Mansour, Riadh ^b   Amouri, Ali ^c   Tahri, Nabil ^c   Lassoued, Saloua ^b   Masmoudi, Hatem ^a  

^a UNIVERSITY OF SFAX   (Tunisia)

^b Université de Sfax   (Tunisia)

^c HEDI CHAKER HOSPITAL   (Tunisia)

Author keywords

Catalase; conjugated dienes; malondialdehyde; protein thiol; superoxide; Tunisia

Indexed keywords

ALKADIENE; CATALASE; MALONALDEHYDE; THIOL;

ADOLESCENT; ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROHN DISEASE; ENZYME ACTIVITY; FEMALE; HUMAN; INTESTINE BIOPSY; INTESTINE MUCOSA; LIPID PEROXIDATION; MALE; OXIDATION; OXIDATIVE STRESS; TUNISIA; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIOXIDANTS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CATALASE; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; SULFHYDRYL COMPOUNDS; TUNISIA; YOUNG ADULT;

EID: 84878523504     PISSN: 13193767     EISSN: 19984049     Source Type: Journal    
DOI: 10.4103/1319-3767.111956     Document Type: Article

References (40)

1. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 2007;117:514-21. (Pubitemid 46348505)
2. Cho JH. The genetics and immune pathogenesis of inflammatory bowel disease. Nat Rev Immunol 2008;8:458-66. (Pubitemid 351733422)
3. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004;126:1504-17. (Pubitemid 38649869)
4. Shih DQ, Targan SR, McGovern D. Recent advances in IBD pathogenesis: Genetics and immunobiology. Curr Gastroenterol Rep 2008;10:568-75.
5. Pavlick KP, Laroux FS, Fuseler J, Wolf RE, Gray L, Hoffman J, et al. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease. Free Radic Biol Med 2002;33:311-22. (Pubitemid 34786271)
6. Pravda J. Radical induction theory of ulcerative colitis. World J Gastroenterol 2005;11:2371-84. (Pubitemid 40667968)
7. Karp SM, Koch TR. Oxidative stress and antioxidants in inflammatory bowel disease. Dis Mon 2006;52:199-207. (Pubitemid 43975094)
8. MacMillan-Crow LA, Crow JP. Does more MnSOD mean more hydrogen peroxide? Anticancer Agents Med Chem 2011;11:178-80.
9. Ames BN. Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science 1983;221:1256-64.
10. Sies H. Role of reactive oxygen species in biological processes. Klin Wochenschr 1991;69:965-8.
11. Kurien BT, Scofield RH. Free radical mediated peroxidative damage in systemic lupus erythematosus. Life Sci 2003;73:1655-66. (Pubitemid 36869006)
12. de M Bandeira S, da Fonseca LJ, da S Guedes G, Rabelo LA, Goulart MO, Vasconcelos SM. Oxidative stress as an underlying contributor in the development of chronic complications in diabetes mellitus. Int J Mol Sci 2013;14:3265-84.
13. Abida O, Gargouri B, Ben Mansour R, Mseddi-Djemal M, Masmoudi A, Ben Ayed M, et al. Biomarkers of oxidative stress in epidermis of Tunisian pemphigus foliaceus patients. J Eur Acad Dermatol Venereol 2012 [Epub ahead of print].
14. Norheim KB, Jonsson G, Harboe E, Hanasand M, Gøransson L, Omdal R. Oxidative stress, as measured by protein oxidation, is increased in primary Sjøgren's syndrome. Free Radic Res 2012;46:141-6.
15. Sklyarov AY, Panasyuk NB, Fomenko IS. Role of nitric oxide-synthase and cyclooxygenase/lipooxygenase systems in development of experimental ulcerative colitis. J Physiol Pharmacol 2011;62:65-73.
16. Best WR. Predicting the Crohn's disease activity index from the Harvey-Bradshaw index. Inflamm Bowel Dis 2006;12:304-10.
17. Lewis JD, Chuai S, Nessel L, Lichtenstein GR, Aberra FN, Ellenberg JH. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis 2008;14:1660-6.
18. Gargouri B, Lassoued S, Ayadi W, Karray H, Masmoudi H, Mokni N, et al. Lipid peroxidation and antioxidant system in the tumor and in the blood of patients with nasopharyngeal carcinoma. Biol Trace Elem Res 2009;132:27-34.
19. Aebi H. Catalase in vitro. Methods Enzymol 1984;105:121-6.
20. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
21. Sies H. Oxidative stress: Oxidants and antioxidants. Exp Physiol 1997;82:291-5. (Pubitemid 27182306)
22. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007;39:44-84. (Pubitemid 44566469)
23. Alzoghaibi MA, Al Mofleh IA, Al-Jebreen AM. Lipid peroxides in patients with inflammatory bowel disease. Saudi J Gastroenterol 2007;13:187-90.
24. Durak I, Yasa MH, Bektas A, Kaçmaz M, Cimen MY, Oztürk HS. Mucosal antioxidant defense is not impaired in ulcerative colitis. Hepato gastroenterology 2000;47:1015-7.
25. Tüzün A, Erdil A, Inal V, Aydin A, Baǧci S, Yeţilova Z, et al. Oxidative stress and antioxidant capacity in patients with inflammatory bowel disease. Clin Biochem 2002;35:569-72. (Pubitemid 35462134)
26. Lassoued S, Gargouri B, El FekiAel F, Attia H, Van Pelt J. Transcription of the epstein-barr virus lytic cycle activator BZLF-1 during oxidative stress induction. Biol Trace Elem Res 2010;137:13-22.
27. Michiels C, Raes M, Toussaint O, Remacle J. Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free RadicBiol Med 1994;17:235-48.
28. Krzystek-Korpacka M, Neubauer K, Berdowska I, Zielinski B, Paradowski L, Gamian A. Impaired erythrocyte antioxidant defense in active inflammatory bowel disease: Impact of anemia and treatment. Inflamm Bowel Dis 2010;16:1467-75.
29. D'Odorico A, Bortolan S, Cardin R, D'Inca' R, Martines D, Ferronato A, et al. Reduced plasma antioxidant concentrations and increased oxidative DNA damage in inflammatory bowel disease. Scand J Gastroenterol 2001;36:1289-94. (Pubitemid 33027808)
30. Boehm D, Krzystek-Korpacka M, Neubauer K, Matusiewicz M, Berdowska I, Zielinski B, et al. Paraoxonase-1 status in Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2009;15:93-9.
31. Reinecker HC, Steffen M, Witthoeft T, Pflueger I, Schreiber S, MacDermott RP, et al. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 1993;94:174-81. (Pubitemid 23308385)
32. Stevens C, Walz G, Singaram C, Lipman ML, Zanker B, Muggia A, et al. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci 1992;37:818-26.
33. Abreu MT, Sparrow MP. Translational research in inflammatory bowel disease. Mt Sinai J Med 2006;73:1067-73. (Pubitemid 46370336)
34. Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 2002;15:79-94. (Pubitemid 34052583)
35. Arutyunova EI, Danshina PV, Domnina LV, Pleten AP, Muronetz VI. Oxidation of glyceraldehyde-3-phosphate dehydrogenase enhances its binding to nucleic acids. Biochem Biophys Res Commun 2003;307:547-52. (Pubitemid 36944967)
36. Shacter E, Williams JA, Levine RL. Oxidative modification of fibrinogen inhibits thrombin-catalyzed clot formation. Free Radic Biol Med 1995;18:815-21.
37. Sheikh Z, Ahmad R, Sheikh N, Ali R. Enhanced recognition of reactive oxygen species damaged human serum albumin by circulating systemic lupus erythematosus autoantibodies. Autoimmunity 2007;40:512-20. (Pubitemid 351233172)
38. Pacifici RE, Kono Y, Davies KJ. Hydrophobicity as the signal for selective degradation of hydroxyl radical-modified hemoglobin by the multi catalytic proteinase complex, proteasome. J BiolChem 1993;268:15405-11. (Pubitemid 23222029)
39. Ben Mansour R, Lassoued S, Elgaied A, Haddouk S, Marzouk S, Bahloul Z, et al. Enhanced reactivity to malondialdehyde-modified proteins by systemic lupus erythematosus autoantibodies. Scand J Rheumatol 2010;39:247-53.
40. Aghdassi E, Wendland BE, Steinhart AH, Wolman SL, Jeejeebhoy K, Allard JP. Antioxidant vitamin supplementation in Crohn's disease decreases oxidative stress. A randomized controlled trial. Am J Gastroenterol 2003;98:348-53. (Pubitemid 36232384)